Micronuclei in lymphocytes from currently active uranium miners
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- centromera genetika účinky záření MeSH
- hornictví * MeSH
- lidé MeSH
- lymfocyty patologie účinky záření MeSH
- mikrojaderné testy MeSH
- mikrojádra chromozomálně defektní účinky záření MeSH
- pracovní expozice škodlivé účinky analýza MeSH
- uran škodlivé účinky MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
- Názvy látek
- uran MeSH
Micronuclei can be used as markers of past radiation exposure, but only few studies have dealt with uranium miners. In this paper, we report on micronuclei in lymphocytes from individuals currently working at Rožná, Czech Republic, the last functioning uranium mine in the European Union. A modified micronucleus-centromere test was applied to assess the occurrence of micronuclei in stimulated lymphocytes, as well as their content in terms of whole chromosomes or fragments. Compared with unexposed individuals, the miners had higher frequencies of micronucleus-containing lymphocytes and higher percentages of micronuclei without centromeres, and the differences were significant for both parameters (0.74 ± 0.60 vs. 0.50 ± 0.42, p = 0.017 and 49 ± 44 vs. 12 ± 21, p = 0.0002; means ± standard deviations). There were also significant correlations between one or other of these parameters on the one hand and various dose values on the other, in particular with a 'retrievable' dose, that is, a dose whose effect should still be recognisable in lymphocytes assuming a half-life of 3 years. The 'retrievable' dose at which a doubling of the micronucleus frequency was observed was around 35 mSv, corresponding to a total dose of 90 mSv received while working in the mines. Altogether, our data show that the micronucleus-centromere test is a valuable tool for the assessment of past radiation exposure in uranium miners. The scatter in the data is of course far too great to allow individual dosimetry, but for groups of a few dozen exposed individuals, the method can be used to monitor doses clearly below 100 mSv.
Zobrazit více v PubMed
Mutat Res. 2010 Aug 14;701(1):80-5 PubMed
Mutagenesis. 1993 Nov;8(6):519-25 PubMed
Mutat Res. 1985 Feb-Apr;147(1-2):29-36 PubMed
Cytogenet Cell Genet. 1993;63(1):54-8 PubMed
J Cell Biol. 1987 Apr;104(4):817-29 PubMed
Eur Heart J. 1985 Oct;6 Suppl C:43 PubMed
Int J Radiat Biol. 1998 Nov;74(5):565-71 PubMed
Int J Radiat Biol. 1990 Feb;57(2):373-83 PubMed
Int J Radiat Biol. 1997 Jan;71(1):61-8 PubMed
Experientia. 1980 Mar 15;36(3):343-4 PubMed
Mutat Res. 1999 Jul 16;428(1-2):99-105 PubMed
Radiat Prot Dosimetry. 2011 May;145(2-3):248-51 PubMed
Int J Radiat Biol. 2001 Nov;77(11):1087-93 PubMed
Radiat Res. 2003 Aug;160(2):152-8 PubMed
Radiat Prot Dosimetry. 2012 May;149(4):371-83 PubMed
Ann Ist Super Sanita. 2009;45(3):260-4 PubMed
Mutat Res. 1995 Feb;334(1):39-47 PubMed
Mutagenesis. 1988 Sep;3(5):415-8 PubMed
Mutagenesis. 2003 May;18(3):221-33 PubMed
Mutagenesis. 2000 May;15(3):245-9 PubMed
Micronuclei in lymphocytes from radon spa personnel in the Czech Republic
